StonvexLoading…
StonvexStonvexStonvexCore line items from AHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.09B | $1.88B | $1.67B | $1.41B |
Operating Income | $415.16M | $363.54M | $306.83M | $301.96M |
Net Income | $69.81M | $-37.81M | $-71.47M | $-81.30M |
EPS (Diluted) | $0.42 | $-0.29 | $-1.08 | $-1.24 |
Total Assets | $5.43B | $4.49B | $4.58B | $4.79B |
Total Liabilities | $2.07B | $2.18B | $3.12B | $3.14B |
Cash & Equivalents | $114.84M | $76.70M | $43.45M | $65.05M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $140.22M |
Shares Outstanding | 166.85M | 130.64M | 66.05M | 65.81M |